-
Mashup Score: 0Blood pressure targets in people with cardiovascular disease - 1 year(s) ago
Your browser does not support the audio element. – Read transcript Mike: Hello, I’m Mike Clarke, podcast editor for the Cochrane Library. Many people with heart or vascular problems also have high blood pressure, and the latest update of the Cochrane Review of using blood pressure targets in their treatment was published in November 2022. Here’s lead author, Luis Carlos Saiz…
Source: www.cochrane.orgCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 2Results of a Remotely Delivered Hypertension and Lipid Program in More Than 10 000 Patients - 1 year(s) ago
This cohort study evaluates the efficacy of a remote hypertension and cholesterol management program vs education only among patients with hypertension and/or high cholesterol in a diverse health care network.
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
“…a standardized remote #BP/#cholesterol mgt program may help optimize GDMT at scale, ⬇️cardiovascular risk, & minimize the need for in-person visits among diverse populations” Results of a Remotely Delivered #HTN and #Lipid Program in >10 000 Pts https://t.co/fYrho3JTb1
-
-
Mashup Score: 6Sex Differences in the Etiology and Burden of Heart Failure across Country Income Level: Analysis of 204 Countries and Territories 1990-2019 - 1 year(s) ago
AbstractBackground. Heart failure (HF) is a global epidemic.Objective. To assess global sex differences in HF epidemiology across country income levels.Methods.
Source: OUP AcademicCategories: Cardiologists, Latest HeadlinesTweet-
📍Top HF causes - #HTN #CAD #RheumaticValve #Alcohol - are treatable/preventable 📍#PrimordialPrevention may be best strategy to ⬇️🌎 HF burden 📍Access to #GDMT imp’t to ⬇️disparities 📍Calcific valve Dz ⬆️ as cause of HF, need to understand pathophysio https://t.co/qAUUfrXwK3 https://t.co/uraLcyyWp3
-
Between 1990-2019 there was an: 1) ⬆️ in #HF cases especially in #LMICs 2) ⬇️ in age-std rates/100K, w/ - greater ⬇️ in M than F - ⬇️ in high income, ⬆️ in low income regions (exception is #MiddleEast which is high income & ⬆️ in age-std prevalence) https://t.co/qAUUfrXwK3 https://t.co/iihSs0pyDo
-
#Global #SexDifferences in #HF led by #SWei PGY3 @McMasterIntMed (her 3rd 📄 on our team) 0f 56.2+ Mill w HF across 🌎in 2019 📍69% live in #LMICs 📍50% F 📍age-std rate/100K greatest in Ms and in #HICs 📍#YLD in M=F 📍#Hypertension #1 cause of HF in F https://t.co/qAUUfrXwK3 https://t.co/2wKFPYUrXv
-
-
Mashup Score: 0How to Denervate With Current Renal Denervation Device Iterations - Cardiac Interventions Today - 1 year(s) ago
Drs. Brian Fulton, Jay Giri, Debbie Cohen, Herbert Aronow, & Taisei Kobayashi show how to denervate with current RDN device iterations, providing a step-by-step guide to RDN for the treatment of hypertension.
Source: Cardiac Interventions TodayCategories: Cardiologists, Latest HeadlinesTweet-
How to Denervate With Current Renal Denervation Device Iterations on @cardiacinterv https://t.co/F4fOeMWGg1 #RDN #HTN #ACCIC @SCAI @VMJ_SVM @HenryFordHealth @HFHCardioFellow
-
-
Mashup Score: 0
Original Article from The New England Journal of Medicine — Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
.#NEJM: Multicenter, Phase 2, placebo-controlled #RCT. Patients with treatment-resistant #hypertension who received #baxdrostat (selective #aldosterone synthase inhibitor) had dose-related reductions in blood pressure. #cortisol #HTN #CVD #NHLBI https://t.co/IOUAg29OeL https://t.co/Ep06rZS3Ti
-
-
Mashup Score: 0
Edema was seen in roughly 10% to 20% of patients, depending on the dose, but it was clinically manageable with diuretics.
Source: TCTMD.comCategories: Cardiologists, Latest HeadlinesTweet-
Endothelin Receptor Antagonist Effective in Resistant #HTN: #PRECISION Edema was seen in roughly 10% to 20% of patients, depending on the dose, but it was clinically manageable with #diuretics @TCTMD @mmamas1973 @ShelleyZieroth @pabeda1 @BiykemB https://t.co/sTZK8Hw2oZ
-
-
Mashup Score: 0
In patients with resistant hypertension, aprocitentan was well tolerated and superior to placebo in lowering blood pressure at week 4 with a sustained effect at week 40.
Source: The LancetCategories: Cardiologists, Latest HeadlinesTweet-
#PRECISION Trial In patients with resistant #HTN , #aprocitentan was well tolerated and superior to placebo in lowering BP at week 4 with a sustained effect at week 40 https://t.co/MRhflYZrHJ @TheLancet #NephTwitter #CardioTwitter @AnastasiaSMihai @DrMarthaGulati @kidney_boy https://t.co/j4Q4cv8zxq
-
-
Mashup Score: 2Longer-Term All-Cause and Cardiovascular Mortality With Intensive Blood Pressure Control - 2 year(s) ago
This secondary analysis of the Systolic Blood Pressure Intervention Trial evaluates the long-term effects of randomization to intensive treatment with the incidence of cardiovascular and all-cause mortality approximately 4.5 years after the trial ended.
Source: jamanetwork.comCategories: Hem/Oncs, Latest HeadlinesTweet-
.#JAMA: @NIH_NHLBI-funded #SPRINT Trial: The beneficial effect of intensive treatment on CV and all-cause #mortality did not persist after the trial. New findings highlight importance of consistent long-term control of #hypertension. #Outcome #ImpSci #HTN https://t.co/zLwYbAmqWA https://t.co/XeXp7qhcp4
-
-
Mashup Score: 13Hydrochlorothiazide Versus Chlorthalidone - 2 year(s) ago
Thiazide diuretics are one of the preferred pharmacologic treatments for hypertension. Hydrochlorothiazide and chlorthalidone have been the 2 most commonly used diuretics in major clinical trials. Tr
Source: HypertensionCategories: Cardiologists, Latest HeadlinesTweet-
@DrMarthaGulati @robmentz @vbluml @AndrewJSauer @iamritu @khurramn1 @ErinMichos @dranulala @SantosGallegoMD @ShelleyZieroth @dramitkhera @AnnMarieNavar @noshreza @AHAScience @Intermountain @APAC_Cardiology This is what I am hoping to see, though would be happy if hctz is equipotent for MACE reduction. Recognizing that they are not equipotent on #HTN lowering at similar mgs. Thoughts @AnastasiaSMihai? #aha22 Earlier lit: https://t.co/W6jM9oViHQ. https://t.co/KdZcLLElvr
-
-
Mashup Score: 1Heart Failure Drug a New Treatment Option for Alcoholism? - 2 year(s) ago
Spironolactone, a potassium-sparing diuretic typically used to treat heart failure and hypertension, has shown promise for alcohol use disorder, a common condition with few treatment options.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Spironolactone, a potassium-sparing diuretic typically used to treat #HF and #HTN, shows promise in treating alcohol use disorder, new research suggests. #DrugRepurposing #MedTwitter https://t.co/x6bpxmKtKD
-
#CochranePodcast - Spend 4 minutes learning about the updated @CochraneHTN review of using blood pressure targets for people with cardiovascular problems, by listening to lead author Luis Carlos Saiz at https://t.co/DSiuK3H45K 🌟Also on @Spotify & @ApplePodcasts #HTN https://t.co/UDPQIagGM9